Ustekinumab-Ttwe 82009-0163
Product NDC
82009-0163- Manufacturer
- Quallent Pharmaceuticals Health Llc
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- April 15, 2025
- Listing Expires
- December 31, 2027
- Application
- BLA761425
Need to source Ustekinumab-Ttwe? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ustekinumab | 130 mg/26mL |
Drug Class
Interleukin-12 Antagonist [EPC]Interleukin-23 Antagonist [EPC]Interleukin-12 Antagonist [EPC]
Packaging Options(1)
1 VIAL, SINGLE-USE in 1 CARTON (82009-163-94) / 26 mL in 1 VIAL, SINGLE-USE